BACKGROUND Absence of cardiovascular risk factors (CVRFs) is traditionally considered low risk for atherosclerosis;
with a low CVRF burden (2) (3) (4) . This is especially the case among younger adults and women, who can experience cardiovascular events despite being considered at low short-term risk (5-7). According to current preventive recommendations (8) , healthy individuals without CVRFs (as presently defined) are usually not considered a target for prevention strategies despite the possible presence of atherosclerosis.
Subclinical atherosclerosis underlies most cardiovascular events, and its detection can improve risk stratification (9, 10) . However, a mismatch has been reported between low conventional risk and the presence of subclinical atherosclerosis detected by coronary artery calcification (CAC) or carotid ultrasound (11, 12) . Our group identified subclinical atherosclerosis in nearly 60% of middle-aged individuals classified at low risk according to traditional risk scales, with multiple vascular sites affected in 41% (13) . These findings demonstrate a disparity between conventional CVRFs and the presence of atherosclerosis, suggesting that other factors play a role in atherogenesis. In this study, we aimed to explore and identify potential predictors of the presence and multiterritorial extent of subclinical atherosclerosis in the absence of major CVRFs.
METHODS
STUDY DESIGN. This study was conducted in a subset of individuals from the PESA (Progression of Early Subclinical Atherosclerosis) study (13) (14) (15) Within the conventional CVRF-free population, we also defined a subgroup of individuals with optimal modifiable CVRFs (3, 18) : systolic blood pressure <120 mm Hg, diastolic blood pressure <80 mm Hg, total cholesterol <200 mg/dl, fasting plasma glucose <100 mg/dl, and glycosylated hemoglobin (HbA 1c ) <5.7%.
ASSESSMENT OF CVRFs, SERUM BIOMARKERS, AND
LIFESTYLE PARAMETERS. CVRFs were prospectively collected through questionnaires (smoking, family history) or objective quantification (hypertension, diabetes, dyslipidemia) as previously described (13) . (20) .
Venous blood was collected after 8 h of fasting and samples were tested for total cholesterol, HDL-C, LDL-C, oxidized LDL-C, triglycerides, lipoprotein (a), glucose, insulin, HbA 1c , cystatin C, and creatinine by standard methods (14) . LDL-C was calculated by the Friedewald method except for participants with triglycerides >300 mg/dl, where it was measured directly. The estimated glomerular filtration rate Flow diagram of the selection process of both the cardiovascular risk factor (CVRF)-free and CVRF-optimal groups from the total PESA (Progression of Early Subclinical Atherosclerosis) study population.
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D E C E M B E R 1 9 , 2 0 1 7 : 2 9 7 9 -9 1 were observed in 56 (3.1%) and 10 (0.6%) participants, respectively. The corresponding long-term risk proportions were 54.6%, 35.6% and 9.8%.
Online Table 1 shows baseline characteristics of the study population (CVRF free) and of the PESA participants with CVRFs. Tables 1 and 2 Table 2 . As expected in this CVRF-free population, ideal metrics were prevalent, although only 121 (6.8%) participants met all 7 ideal criteria. Significant differences in these health metrics between those with and without atherosclerosis were found for blood pressure, total cholesterol, glucose, and body mass index, but not for smoking, physical activity, and diet.
Despite the absence of conventional CVRFs, subclinical atherosclerosis was highly prevalent (49.7%).
Overall, 46.7% had peripheral atherosclerotic plaques: 22.7% in the carotid arteries, 17.2% in the infrarenal aorta, and 30.1% in the iliofemoral arteries. Fernández-Friera et al.
D E C E M B E R 1 9 , 2 0 1 7 : 2 9 7 9 -9 1 CAC was detected in 11.1% of participants, the majority of them with mild calcification (183 individuals with a CAC score <100, 14 with a score of 100 to 399, Tables 5 and 6 ). In multivariable models, male sex, age, LDL-C, and HbA 1c were associated with the presence of disease ( Table 3) . Age and sex showed the strongest associations with atherosclerosis presence, followed by LDL-C (Figure 2) . The same variables, and additionally VCAM-1 and cystatin C, were also associated with multiterritorial extent of atherosclerosis (Table 3 ). Figure 3 Values are mean AE SD, n (%), or median (interquartile range). The p values were calculated for all participants and also for those with atherosclerosis. *n ¼ 1,749. †n ¼ 1,768.
Abbreviations as in Table 1 .
increasing disease extent in the CVRF-free group, and only age and triglycerides in the CVRF-optimal group; however, sample size in the latter analysis was too small (Online Table 7 ).
In the subgroup with optimal CVRFs, age, male sex, and LDL-C were the only variables significantly associated with both disease presence and multiterritorial extent ( Table 3) . Similar to the overall population, age and male sex had the strongest associations with the presence and extent of atherosclerosis ( Figure 2) .
In both the CVRF-free and CVRF-optimal groups, results were similar when LDL-C was replaced by non-HDL-C (Online Table 8 ).
PREDICTORS OF ATHEROSCLEROSIS IN PARTICIPANTS
WITH LDL-C <130 MG/DL. Similar results were obtained in a further multivariable analysis restricted to individuals with LDL-C <130 mg/dl (1,107 CVRF free and 682 CVRF optimal). Age, male sex, and LDL-C were the only variables associated with atherosclerosis presence and multiterritorial extent in both groups.
In the CVRF-free group only, HbA 1c was also associated with both atherosclerosis presence and extent, and fibrinogen with extent ( Table 4) .
The relationship between LDL-C and atherosclerosis in the absence of dyslipidemia, hypertension, diabetes, and smoking is illustrated in the Central Illustration and Figure 4 . As LDL-C levels increased, there was a linear and significant increase in the prevalence of atherosclerosis, ranging from 11% in the 60 to 70 mg/dl category to 64% in the 150 to 160 mg/dl subgroup (p < 0.001) (Central Illustration).
This progressive increase was noted in both men
and women (Online Figure 1) . A similar pattern was observed for the number of vascular sites affected (Central Illustration) and for each vascular bed analyzed separately ( Figure 4) . Indeed, in a secondary analysis by each vascular territory, LDL-C remained associated with atherosclerosis presence in each territory for the total CVRF-free population (Online Table 9 ).
Finally, we also assessed whether LDL-C tracked atherosclerosis similarly across 30-year Framingham risk score categories. Whereas there was influence in 
Presence Multiterritorial Extent
Age and sex showed the strongest associations with atherosclerosis presence and multiterritorial extent, followed by low-density lipoprotein cholesterol (LDL-C) in both the cardiovascular risk factor (CVRF)-free population and in the CVRF-optimal subgroup.
Standardized odds ratios are expressed per SD increase in each continuous risk factor.
Odds ratios for sex are for men versus women. HbA1c ¼ glycosylated hemoglobin;
VCAM ¼ vascular cell adhesion molecule.
Fernández-Friera et al. Table 10 ). Age and male sex demonstrated the strongest associations, followed by LDL-C. Odds ratios (ORs) were adjusted for age, sex, LDL-C, HbA1c, cystatin C, and VCAM-1.
Quintile 1 served as the reference category. Vertical bars represent 95 percent confidence intervals. Abbreviations as in Figure 2 . Abbreviations as in Table 1 .
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DISCUSSION
Fernández-Friera et al. This hypothesis is consistent with recent lipidlowering trials, in which adverse clinical outcomes were significantly reduced when LDL-C levels were lowered below current targets (37) . Thus, our findings may have important implications for primordial prevention strategies and for establishing cutoff values to define lipid disorders.
Additional independent (and nonmodifiable) predictors of atherosclerosis included age and sex. It is known that age is the most significant risk factor for cardiovascular events (8), and we also showed a strong association with subclinical atherosclerosis. This is likely related to the longer exposure to a variety of atherosclerotic risk determinants (e.g., LDL-C) as well as other aging-associated phenomena such as increased nucleic acid damage, apoptosis, or reduced regenerative capacity (38) . Sex-based differences in atherosclerosis prevalence and severity are also well described, with women experiencing their first clinical event a decade later than men on average (39) . Underlying mechanisms are incompletely understood but are probably multifactorial, including estrogen levels as well as differences in risk factor prevalence and susceptibility, psychosocial factors, and vascular biology (40) .
In our study, HbA 1c was also independently asso- Although each of these markers has potential mechanistic links to atherosclerosis, we did not find consistent associations in our models, and their link to atherosclerosis in the absence of CVRFs needs further investigation. Interestingly, blood pressure was not associated with systemic atherosclerosis in our sample, although we found a link with carotid disease (Online Table 9 ). We observed a paradoxical response between subclinical disease and healthy lifestyle parameters, such as diet and physical Recent U.S. guidelines (19) propose different optimal CVRF thresholds, but only 97 (5.5%) participants in our study fulfilled these criteria (not shown), again precluding meaningful multivariable analysis.
Similarly, we could not perform multivariable analysis using a more restrictive LDL-C cutoff (<100 mg/dl) because of insufficient power (n ¼ 235, not shown). In any case, our findings strongly suggest that thresholds to define elevated LDL-C should be lower than recommended across current guidelines.
STUDY LIMITATIONS. In the PESA study, diabetes was diagnosed based on glucose levels and not on Prospective studies are needed to evaluate the efficacy of more aggressive LDL-C lowering strategies at both the individual and population levels to reduce the incidence of clinical ischemic events.
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